Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Brandie C. Taylor, Justin M. Balko
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 263
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1212-1224
Open Access | Times Cited: 46
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3474-3474
Open Access | Times Cited: 45
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 24
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
Pan Zheng, Guanglei Wang, Bin Liu, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 3
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche
Jayanta Mondal, Junfeng Zhang, Qing Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Next-generation antigen-presenting cell immune therapeutics for gliomas
Catalina Lee-Chang, Maciej S. Lesniak
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 30
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
Qi Wang, Zhangzuo Li, Shujing Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
Biying Zhang, Jiao Li, Qingling Hua, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005592-e005592
Open Access | Times Cited: 24
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance
Mahboubeh Tajaldini, Amirhoushang Poorkhani, Taghi Amiriani, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175991-175991
Closed Access | Times Cited: 24
The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials
Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115888-115888
Open Access | Times Cited: 23
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
Daniel S. Lefler, Steven Manobianco, Babar Bashir
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 15
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors
Tomáš Jelı́nek, David Žihala, Tereza Ševčíková, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1323-1333
Open Access | Times Cited: 14
NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Zhiheng Zhang, Bojiao Song, Haowei Wei, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101040-101040
Closed Access | Times Cited: 12
Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications
Jun Yin, Tiezheng Gu, Norin Chaudhry, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
S. Evans, Yash Jani, Caroline S. Jansen, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 11
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 10
Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy
Fotios Mpekris, Myrofora Panagi, Antonia Charalambous, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101626-101626
Open Access | Times Cited: 10
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 10
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
Xiaobo Luo, Yan Qiu, Zackary R. Fitzsimonds, et al.
Oncogene (2024) Vol. 43, Iss. 6, pp. 388-394
Closed Access | Times Cited: 9
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
René Novysedlák, Miray Guney, Majd Al Khouri, et al.
Oncology (2024), pp. 1-25
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top